Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Alicia M. Maceira(The Royal Free Hospital), Dudley J. Pennell(Guy's and St Thomas' NHS Foundation Trust), Enrica Perugini(The Royal Free Hospital), Philip N. Hawkins(The Royal Free Hospital), Idris Harding(The Royal Free Hospital), Sanjay Prasad(Royal Brompton Hospital), Philip A. Poole‐Wilson(Mario Negri Institute for Pharmacological Research), James Moon(University of Michigan), Jayshree Joshi(The Royal Free Hospital), Mary N. Sheppard(St George's, University of London)
Cited by 978
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
The Seattle Heart Failure Model
|Circulation|2006|2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k